With over 23 years of experience, including over a decade in internationally focused healthcare and life sciences, Brad has successfully participated in the capitalization and global expansion of many emerging growth companies. He is the Chief Business Officer of HaraeDx, an oncology diagnostic startup in Silicon Valley developing a highly accurate yet inexpensive and accessible single drop blood test for breast cancer. Brad is also the Co-Head of Go Asia SEA which, in conjunction with Go Asia China, provides regional market and commercial access to foreign companies. Previously he was the Head of China and Venture Partner of 7BC Venture Capital, focusing on the establishment of a family of JV RMB funds across mainland China. He was also a Managing Director at Katan Associates since 2014 and was the Vice President, Business Development of POC Medical Systems. Prior to entering the healthcare space Brad originated and executed a successful hedge fund strategy returning 464% over five years and also participated in over $20 billion in debt and equity transactions in investment banking roles.